Status:
WITHDRAWN
A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected Patients
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
HIV Infections
Eligibility:
All Genders
13+ years
Phase:
PHASE2
Brief Summary
To compare the long-term virologic response to combination therapy with two protease inhibitors, i.e., nelfinavir (NFV) + saquinavir soft gel capsule (SQVsgc) and delavirdine (DLV) or combination lami...
Detailed Description
Past studies have shown that combination therapies not only will result in better clinical outcomes but may prolong the effects of therapy. The enhanced effects seen with combination therapies are lik...
Eligibility Criteria
This study has been terminated.
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00001094
Last Update
March 9 2015
Active Locations (17)
Enter a location and click search to find clinical trials sorted by distance.
1
Willow Clinic
Menlo Park, California, United States, 94025
2
Stanford Univ Med Ctr
Stanford, California, United States, 943055107
3
Univ of Colorado Health Sciences Ctr
Denver, Colorado, United States, 80262
4
Univ of Miami School of Medicine
Miami, Florida, United States, 331361013